Binary Cu/boron enhanced graphene quantum dots as a biomimetic nanocatalyst for Trp catabolism to indole-3-aldehyde: mechanism and specificity
Materials Horizons · 2026 · 13 (13) · 6462-6475
DOI: 10.1039/d6mh00264a ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Horizons, 2026. Verfasst von Morteza Hasani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Chemical Biology Research Laboratory, Chemistry Department, Sharif University of Technology, PO Box: 11365-11155, Tehran, Iran. kalh…. Hauptthemen laut MEDLINE: Indoles, Graphite, Tryptophan, Quantum Dots. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Multienzyme-like nanocatalysts offer a useful platform for studying complex biochemical transformations. Herein, we demonstrate that a Cu/boron-GQD nanozyme can effectively mimic the native catabolism of tryptophan to indole-3-aldehyde.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biochemistry and Chemical Biology Research Laboratory, Chemistry Department, Sharif University of Technology, PO Box: 11365-11155, Tehran, Iran. kalhor@sharif.edu.
- Institute for Convergence Science & Technology, Sharif University of Technology, Tehran, Iran.
Zitieren
APA
Hasani, M., & Kalhor, H. R. (2026). Binary Cu/boron enhanced graphene quantum dots as a biomimetic nanocatalyst for Trp catabolism to indole-3-aldehyde: mechanism and specificity. Materials Horizons, 13(13), 6462-6475. https://doi.org/10.1039/d6mh00264a
Vancouver
Hasani M, Kalhor HR. Binary Cu/boron enhanced graphene quantum dots as a biomimetic nanocatalyst for Trp catabolism to indole-3-aldehyde: mechanism and specificity. Materials Horizons. 2026;13(13):6462-6475. doi:10.1039/d6mh00264a
BibTeX
@article{Hasani2026,
author = {Hasani, Morteza and Kalhor, Hamid R},
title = {Binary Cu/boron enhanced graphene quantum dots as a biomimetic nanocatalyst for Trp catabolism to indole-3-aldehyde: mechanism and specificity},
journal = {Materials Horizons},
year = {2026},
volume = {13},
number = {13},
pages = {6462--6475},
doi = {10.1039/d6mh00264a}
}
EUVIMED